🟢 STAAR Surgical is trading 6.9% up today after Stifel upgraded it to Buy

STAAR Surgical is trading 6.9% up at $22.30 on September 29, following Stifel’s upgrade from Hold to Buy and price-target increase from $28 to $31, a plausible catalyst for the move.

• Stifel cited expected China growth from the EVO+ product-mix shift and easier comparisons outside China.
• The upgrade was reported early September 29; major indexes were little changed.
• No separate company announcement dated September 29 was identified in the sources reviewed.